Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist (Multicentric)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorClinica Universidad de Navarra, Universidad de Navarra

About this trial

1\. Introduction

Scheduled surgery requires patients to undergo a preoperative fasting period of at least 6 hours to reduce the risk of perioperative pulmonary aspiration. However, certain medications and conditions may delay gastric emptying, potentially increasing aspiration risk. These include diabetic gastroparesis and the use of glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of diabetes and obesity.

GLP-1 receptor agonists are widely used due to their beneficial effects on glycemic control and weight reduction. However, one of their known effects is delayed gastric emptying, which may result in increased residual gastric content despite adherence to standard fasting guidelines. Recent reports have described cases of pulmonary aspiration during anesthesia in patients receiving GLP-1 receptor agonists, even after appropriate fasting.

Given the increasing use of these medications, there is a need for objective assessment tools to evaluate gastric content in the perioperative setting. Gastric ultrasonography has emerged as a non-invasive bedside technique that may help identify patients at increased risk of aspiration and guide airway management strategies.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

- History of esophagogastric pathology or previous abdominal surgery.

- Hiatal hernia/gastroesophageal reflux disease.

- Autonomic nervous system disorders.

- Neurological or neuromuscular diseases.

Trial population

The reference population will consist of patients undergoing scheduled surgery with a conventional preoperative fasting period (at least 6 hours).

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Gastric Ultrasound

    Diagnostic test

    Gastric Ultrasound

Treatment groups

39 Participants
are divided into 1 treatment group
Group A: Treatment with GLP-1 agonists1 intervention

Trial outcomes

Primary outcomes

1

Gastric Ultrasound

Gastric ultrasonography performed by trained anesthesiologists, for measuring gastric content in volume (cm3) is a useful tool for assessing gastric content and making clinical decisions regarding airway management.

Time frame
Immediately prior to induction of anesthesia

Secondary outcomes

1

weight in kilograms

Weight in kilograms

Time frame
Immediately prior to induction of anesthesia
2

Height in centimeters

Height in centimeters

Time frame
Immediately prior to induction of anesthesia
3

BMI in kg/m^2

Weight and height will be combined to report BMI in kg/m\^2

Time frame
Immediately prior to induction of anesthesia

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.